Rubedo
Operator of a biopharmaceutical company intended to commercialize novel therapeutics that target and eliminate senescent cells. The company's platform utilizes selective apoptosis of cells in aged or ...
Valuation
$90M
Market implied
Share Price
N/A
Total Raised
$52M
Last Round
N/A